HBsAb


Also found in: Medical.
AcronymDefinition
HBsAbHepatitis B Surface Antibody
HBsAbHarvard Business School Association of Boston (Belmont, MA)
References in periodicals archive ?
Markers of hepatitis B virus in mothers and vertical transmission of the virus Markers of HBV in HBV- mother HIV+ DNA HBsAg HBeAg A 5 + + + B 2 - + - C 7 - - - Vertical HBV HBsAb HBeAb HBcAb transmission A - - + 3 B - + - 0 C - - + 0
Of the infants, 19/122 in the group tested with the quantitative kit had an HBsAb level <10 mIU/mL and 12/78 were negative with the qualitative test, giving a total of 31 non-responders (15.5%) (Table 3).
Regarding HCV, 4.7% of children were diagnosed as HCV seropositive by ELISA for anti-HCV while 58.5% were HBV seroprotective (HBsAb >10 mIU/ml).
Indeed, after 2 months of this treatment a complete resolution of tubulopathy was observed and after 6 months a complete HBs seroconversion (HBsAg negative; HBsAb: 15 UI/ml) occurred (Figure 1).
The following lab results were recorded: HEP B VIRAL DNA IU/ML was 32,950 (LOG10 HBV AS IU/ML 4.518 log10 IU/ml); Hepatitis B core IgM was negative; HBsAB was <3.1; Hepatitis B e Antigen was negative.
Unfortunately, HBsAb levels decline more rapidly in immunosuppressed patients, even in those who develop protective levels [10,13], and booster doses produce blunted responses [10].
Sequence analysis of the S gene region in HBV DNA from patients positive for both HBsAg and HBsAb tests.
In practice, regular monitoring for viral reactivation during therapy, particularly in patients lacking evidence of immunity (HBsAb negative), is necessary.
Ten of the Wrong Test Data-Entry errors occurred when clinicians requested Hepatitis B surface antibody tests ('HBsAb') but CSR staff erroneously entered requests for Hepatitis B surface antigen tests ('HBsAg') into the LIS, or vice versa.
Minnesota Department of Health, Thomas Jefferson University, and Yale-New Haven Hospital also submitted data on hepatitis B surface antibody (HBsAb) and hepatitis B core antibody (HBcAb), which permitted more comprehensive evaluation of current HBV status and previous exposure.
A total of 27 DNA samples from healthy individuals who had nonpathologic liver function and no history of HBV infection [HBsAg, HBV surface antibody (HBsAb), HBeAg, HBeAb, and HBcAb were negative by serological tests, and HBV DNA was undetectable by qPCR] served as negative controls.